Company receives the highest evaluation in Korea’s bio industry by MSCI.Company has received an A gr...

Company takes part in Ministry of Environment’s driven campaign to reduce carbon emissions and devel...

-Vaccination with Novavax’s updated COVID-19 vaccine will commence at hospitals and public health ce...

-Phase III studies IND amendment has been submitted based on positive safety and immunogenicity data...

-This marks the fourth approval of Novavax´s updated COVID-19 vaccine globally, following approvals ...

On November 28th, the board of directors decided to invest in the expansion of L HOUSE, a vaccine ma...

SK bioscience will partner with Hilleman Laboratories Singapore to develop a low-cost, improved manu...

H.E Dr. Jean Kaseya, Director General of the African Centers for Disease Control and Prevention (Afr...

SK bioscience plans to introduce the only updated protein-based non-mRNA, COVID vaccine for South Ko...

First among South Korea’s clinical trial sample analysis institutions, SK bioscience implements a La...

-Ana Brnabi?, Prime Minister of Serbia visited the SK bioscience headquarters.-SK bioscience signed ...

-SK bioscience and Vaxxas have officially entered into a Joint Development Agreement. This collabora...